👶 Newborn Screening

Newborn screening is a simple procedure performed 48-72 hours after birth to detect congenital metabolic disorders. These disorders can lead to mental retardation or even death if left untreated. The process involves a simple heel stick to collect a few drops of blood on a special paper card.

📝 Disorders Screened

The initial newborn screening includes six disorders:

1. Congenital Hypothyroidism (CH)

2. Congenital Adrenal Hyperplasia (CAH)

3. Phenylketonuria (PKU)

4. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

5. Galactosemia (GAL)

6. Maple Syrup Urine Disease (MSUD)

📜 Legal Framework

These screenings are mandated by Republic Act 9288, also known as the Newborn Screening Act of 2004.

➕ Expanded Screening

In 2012, expanded screening was implemented, including 22 more disorders such as hemoglobinopathies and additional metabolic disorders, namely:

• Organic acid disorders

• Fatty acid oxidation disorders

• Amino acid disorders

🧑‍⚕ Sample Collection

Samples for newborn screening can be collected by:

• Trained physician

• Nurse midwife

• Medical technologist

🏥 Availability

Newborn screening is available in participating Newborn Screening Facilities, including:

• Hospitals

• Lying-in centers

• Rural Health Units (RHUs)

• Health centers

For babies delivered at home, they may be brought to the nearest Newborn Screening Facility.

⏳ Result Availability

Results are typically available within seven working days from the time the samples are received. Parents should claim the results from their physician, nurse, midwife, or health worker. Positive screens are released within 24 hours to allow for immediate confirmatory testing.

❗ Out of Range Results

If the screening detects one or more conditions, the result is "positive" or "out of range." This does not definitively mean the child has the condition, as false positives can occur. Additional testing is essential to confirm the diagnosis.

역할 RHU Staff Roles

RHU staff play crucial roles in:

• Advocating for newborn screening for every baby, starting during pregnancy.

• Advising families to start saving for the screening fee (Php550.00).

• Collecting samples.

• Ensuring transport of specimens to the nearest Newborn Screening Facility within 24 hours following collection.

• Advising and counseling parents upon receiving screening results.

📉 Congenital Hypothyroidism (CH)

Congenital hypothyroidism (CH) can be permanent or transient and may have various causes.

Congenital Hypothyroidism (CH) Definition: A condition that may have a number of causes and can be either permanent or transient. Transient CH is frequently associated with maternal Graves Disease that was treated with antithyroid drugs.

The majority of cases are sporadic (nonhereditary), but approximately 15% are transmitted as an autosomal dominant trait. Worldwide, the most common cause of CH is iodine deficiency.

🩺 Pathogenesis

The most common pathogenesis is thyroid dysgenesis, mostly with unknown causes.

🧠 Importance of Early Detection

Early detection and prompt treatment are essential to prevent cognitive impairment. The IQ loss is directly related to the time treatment is initiated:

• Treatment implemented from 0 to 3 months: IQ of 89 (range, 64-107)

• Treatment from 3 to 6 months: IQ of 71 (range, 36-96)

• Treatment after 6 months: IQ of 54 (range, 25-80)

👶 Transient Hypothyroidism in Preterm Infants

Many preterm infants have transient hypothyroidism (hypothyroxinemia) at birth due to hypothalamic and pituitary immaturity. Infants born before 28 weeks of gestation may require temporary thyroid hormone replacement.

🧪 Neonatal Screening

Neonatal screening involves an initial filter paper blood spot thyroxine (T4) measurement followed by measurement of thyroid stimulating hormone (TSH) in specimens with low T4 values. The test is best obtained between 2 and 6 days of age. Early screening can result in overdiagnosis (false-positives).

🔬 Additional Tests

Additional tests include serum measurement of T4, triiodothyronine (T3), resin uptake, free T4, and thyroid-bound globulin. Tests of thyroid gland function usually involve oral administration of a radioactive isotope of iodine (131I) and measurement of iodine uptake by the thyroid gland.

📈 Thyroid Hormone Concentrations

After birth:

• TSH surges immediately, peaking at 30 minutes.

• T3 and T4 rapidly rise, peaking at 24 hours after delivery.

• T4 and T3 decline to stable concentrations.

🧪 Thyroid Function Studies

In CH:

• Protein bound iodine, T4, T3, and free T4 levels are low.

• Thyroid uptake of 131I is decreased.

In newborns, thyroid function studies are elevated compared to older children. In preterm and sick full-term infants, thyroid function tests are usually lower than in healthy full-term infants. Repeat T4 and TSH may be evaluated after 30 weeks (corrected age) in newborns born before that time and after resolution of the acute illness in sick full-term infants.

💊 Phenylketonuria (PKU)

Phenylketonuria (PKU) Definition: An inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine.

Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorders. It may also result in a musty smell and lighter skin.

🧬 Causes

PKU is caused by mutations in the PAH gene, which provides instructions for making the enzyme phenylalanine hydroxylase. This enzyme is necessary for converting phenylalanine into tyrosine, another amino acid. If the enzyme is deficient or absent, phenylalanine accumulates in the bloodstream and becomes toxic, particularly to the brain.

Phe↛TyrPhe↛Tyr

PKU is inherited in an autosomal recessive pattern.

📉 Symptoms

Symptoms of PKU typically present within the first few months of life and can include:

• Intellectual disability and developmental delays

• Behavioral problems (hyperactivity, mood disorders)

• Seizures

• Skin conditions (eczema)

• Musty or "mousy" odor in the breath, skin, or urine due to phenylacetate

• Slow growth

• Hypopigmentation (lighter skin and hair)

🧪 Diagnosis

• Newborn Screening: Detects elevated levels of phenylalanine in the blood.

• Confirmatory Testing: Genetic testing and phenylalanine levels analysis.

The Guthrie test, also called the PKU test, is a diagnostic tool to test infants for phenylketonuria.

A normal phenylalanine level in newborns is considered to be between 0.5mg to 1mg per deciliter (dL) of blood, which translates to roughly 30 to 60 micromoles per liter (mol/L).

🍎 Management

• Dietary Management: A low-phenylalanine diet, typically starting soon after birth.

  • Avoiding high-protein foods (meat, dairy, eggs, nuts) and foods containing aspartame.

  • Supplementing the diet with low-phenylalanine medical foods and amino acid supplements.

• Regular Monitoring: Frequent blood tests to monitor phenylalanine levels.

• Phenylalanine-reducing Therapies: Medications such as sapropterin dihydrochloride (Kuvan) may be used.

👩‍⚕ Nursing Management

• Education: Instruct patients and families on dietary restrictions and adhering to the treatment plan.

• Monitoring Growth and Development

• Support and Counseling

• Coordination of Care: Collaborate with dietitians, social workers, and specialists.

🥛 Galactosemia

Galactosemia Definition: A rare autosomal recessive genetic disorder characterized by an inability to metabolize galactose, a sugar found in milk and dairy products, due to deficiencies in specific enzymes.

The most common form is classic galactosemia, which results from a deficiency in the enzyme galactose-1-phosphate uridylytransferase (GALT).

⚙ Pathophysiology

• Accumulation of Galactose: Galactose cannot be properly metabolized, leading to the accumulation of galactose-1-phosphate and other toxic metabolites in the bloodstream.

• Tissue Damage: The accumulation of these metabolites causes damage, particularly to the liver, brain, kidneys, and eyes.

• Lactose Consumption Impact: Consumption of dairy products exacerbates the condition.

📉 Symptoms

Symptoms of galactosemia usually appear shortly after birth and may include:

• Jaundice (yellowing of the skin and eyes)

• Vomiting

• Poor feeding and failure to thrive

• Lethargy

• Hypoglycemia (low blood sugar)

• Liver damage or enlargement

• Susceptibility to infections

• Cataracts

If not diagnosed and treated promptly, galactosemia can lead to serious complications and long-term health issues, including intellectual disability.

🏥 Medical Management

• Dietary Management: The primary treatment involves the elimination of lactose and galactose from the diet.

  • Avoiding all milk and dairy products.

  • Restricting foods that contain galactose, such as certain fruits and legumes.

  • Providing alternatives like lactose-free formulas and soy-based products.

• Continuous Monitoring: Regular follow-up and monitoring of galactose levels in the blood.

• Management of Complications: Address any complications that arise, including cataract surgery if required.

When purchasing foods:

• Read the label on all packaged foods.

• Do not buy foods that list milk, butter, cream, yogurt, cheese, nonfat dry milk or milk solids, whey or whey solids (milk proteins), casein (milk protein), or lactose (milk sugar).

• If there is no label or the contents are not listed, do not eat this food

👩‍⚕ Nursing Management

• Patient and Family Education: Educate families about the nature of galactosemia, dietary restrictions, and the importance of lifelong avoidance of galactose in various foods.

• Nutritional Support: Work with a dietitian to ensure the patient receives adequate nutrition and a balanced diet while avoiding galactose.

• Psychosocial Support: Provide emotional support to families and patients managing a chronic condition, addressing any concerns regarding growth, development, and social interactions.

• Regular assessments: Monitor growth parameters and developmental milestones.

🩸 Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD)

Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD) Definition: A genetic disorder that leads to reduced levels of the G6PD enzyme, which is essential for normal functioning of the red blood cells.

The deficiency can result in hemolytic anemia, particularly in response to certain triggers.

🧬 Types

• Mediterranean (G6PD med): More severe, with every new RBC deficient in the G6PD enzyme (10% of normal).

• African (G6PDA): Young RBCs maintain an adequate G6PD enzyme level for a longer time (G6PD activity is around 20% to 60%).

This is an X-linked (sex-linked) genetic abnormality, carried by the female (X-chromosomes). The defect is more severe in the male (XY) and a much smaller number of the females in whom both XX chromosomes have abnormal genes. If only one X-chromosome is abnormal in the females, these are carriers. These may be asymptomatic to moderate abnormality, even in the case of stimulation.

🧪 Classification of G6PD Deficiency

Based on the amount of the enzyme:

1. Class 1: <5% of normal RBCs enzyme activity.

   • Rare

   • Chronic, congenital, and nonspherocytic hemolytic anemia

   • Worsened by oxidant drugs or febrile illness

   • Does not improve by splenectomy

2. Class 2: <10% of the normal RBCs enzyme activity.

   • Acute hemolytic crises induced by oxidant drugs

   • May be seen in acidosis

   • No improvement by splenectomy

3. Class 3: 10% to 60% of the RBCs enzyme activity.

   • Hemolytic crises induced by oxidant drugs or infections

   • Hemolysis is self-limiting

   • Seen in hepatic coma, hyperthyroidism, myocardial infarction, megaloblastic anemia, and chronic blood loss

4. Class 4: Very mild or no deficiency of the G6PD enzyme.

5. Class 5: Increased activity (only one such variant was described).

Classes 2 and 3 represent 90% of the cases. Classes 4 and 5 show no clinical signs or symptoms.

🍎 Factors Causing Hemolysis

1. Vegetables like Fava beans.

2. Drugs: Chloramphenicol.

3. Antimalarial drugs like: Primaquine, Dapsone, Pamaquine, Chloroquine, Quinine.

4. Antibacterial drugs like: Sulphonamide, Sulphones like co-cotrimoxazole, sulfanilamide, dapsone, and salazopyrin.

5. Analgesics like: Asprin, Acetanilide, Phenacetin

6. Antihelminths like stibophen and naphthol.

7. Other agents like vitamin K, probenecid, naphthalene, nalidixic acid, dimercaprol, and phenylhydrazine.

Favism: The grave end result of G6PD deficiency of the RBCs.

• Hemolysis may be sudden in onset.

• Reported within the first hours after exposure to the fava beans.

• In most cases, onset is gradual; hemolysis is noticed in 1 to 2 after the beans ingestion.

• The urine will become red or quite dark.

• In severe cases, the patient may go into shock.

📉 Symptoms

Symptoms of G6PD deficiency can vary widely and may not be present until hemolysis occurs. Common symptoms include:

• Fatigue

• Jaundice (yellowing of the skin and eyes)

• Dark urine

• Shortness of breath

• Rapid heart rate

• Abdominal or back pain

🧪 Diagnosis

Diagnosis is typically made through:

• Blood tests: Measuring G6PD enzyme activity levels.

• Complete blood count (CBC): To check for anemia and elevated reticulocyte count.

• Blood smear: May show "bite cells" or "Heinz bodies".

• Definitive diagnosis by enzyme assay of RBCs.

In an acute attack, the screening test is normal. But in the asymptomatic phase, the screening test will be abnormal, indicating deficiency.

❗ Complications

Complications of G6PD deficiency may include:

• Acute hemolytic anemia

• Severe jaundice

• Chronic kidney issues

⚙ Pathophysiology

In G6PD deficiency, the lack of the enzyme impairs the production of NADPH, which is crucial for maintaining the reduced state of glutathione in red blood cells. This vulnerability leads to oxidative stress, causing damage to red blood cells and resulting in hemolysis, especially under oxidative stress conditions.

G6PD⟶NADPHG6PD⟶NADPH

🏥 Management

Management includes:

• Avoidance of triggers: Patients are advised to avoid certain medications, foods, and situations that can induce hemolysis.

• Supportive care: In cases of hemolytic anemia, treatment may include hydration, transfusions, or medications.

• Folic acid supplements: To help support red blood cell production.

• Babies having a deficiency of G-6-PD deficiency will have neonatal jaundice. These babies need phototherapy and maybe a blood transfusion.

👩‍⚕ Nursing Management

Nursing management strategies may include:

• Education: Informing patients about lifestyle modifications and avoiding triggers.

• Monitoring: Regular assessments for signs of hemolysis and managing symptoms.

• Nutritional support: Advising on a healthy diet, including the potential need for supplements.

⚙ Congenital Adrenal Hyperplasia (CAH)

Congenital Adrenal Hyperplasia (CAH) Definition: A collection of inherited disorders that result from enzyme deficiencies in the adrenal glands, leading to impaired cortisol and aldosterone synthesis and increased production of adrenal androgens. The most common form is 21-hydroxylase deficiency.

🧪 Adrenal Gland Hormones

The adrenal glands produce hormones your body needs to function properly:

1. Cortisol: Helps your body respond to illness, injury, and stress. It also regulates blood pressure, energy levels, and blood sugar levels.

2. Aldosterone: Helps your body maintain the correct levels of salt (sodium) and water. It also controls blood pressure and blood volume.

3. Androgen: Male sex hormones such as testosterone. They help kick off puberty and play an important role in normal growth and development.

If you have CAH, you lack a specific enzyme your adrenal glands need to make one or more of these hormones. Without this enzyme, your adrenal glands:

• May not produce enough cortisol.

• May not produce enough aldosterone.

• May produce too much androgen.

🧬 Types of CAH

1. Classic congenital adrenal hyperplasia (CAH)

   • Salt-wasting CAH

   • Simple-virilizing CAH

2. Nonclassic congenital adrenal hyperplasia (CAH)

📉 Symptoms

The symptoms can vary based on the severity of the enzyme deficiency and the age of presentation:

• Infants:

  • Ambiguous genitalia in females

  • Early virilization in males

  • Salt-wasting crisis (low sodium and high potassium)

  • Poor feeding and dehydration

• Older children and adults:

  • Rapid growth in childhood

  • Early onset of puberty

  • Irregular menstrual cycles in females

  • Acne and hirsutism

🧪 Diagnosis

Diagnosis typically involves:

• Newborn screening: Measuring 17-hydroxyprogesterone (17-OHP) levels in the blood.

• Hormonal assays: Blood tests to check levels of cortisol, aldosterone, and androgens.

• Genetic testing: To identify specific mutations associated with enzyme deficiencies.

At birth, normal levels of:

• cortisol 10-20 mcg/dL

• aldosterone 5-20 ng/dL

• androgens below 1000 ng/dL

❗ Complications

Potential complications of CAH may include:

• Adrenal crisis

• Infertility

• Crisis events: Such as severe hyponatremia or hyperkalemia leading to cardiovascular complications.

• Long-term health issues: Including growth impairment, osteoporosis, and psychological impact due to gender dysphoria in intersex cases.

⚙ Pathophysiology

In CAH, enzymatic defects disrupt the pathway for cortisol and aldosterone synthesis. As a result, precursor hormones accumulate, leading to increased production of androgens and a deficiency in cortisol and aldosterone. The lack of cortisol can trigger excessive adrenocorticotropic hormone (ACTH) production from the pituitary gland, exacerbating adrenal hyperplasia (enlargement).

🏥 Management

Management strategies include:

• Hormone replacement therapy: Glucocorticoids (e.g., hydrocortisone) to replace cortisol, and if necessary, mineralocorticoids (e.g., fludrocortisone) to replace aldosterone.

• Monitoring: Regular assessment of hormone levels and patient growth.

• Salt supplementation: In cases of salt-wasting CAH.

👩‍⚕ Nursing Considerations

Nursing considerations may involve:

• Education: Providing information about CAH, including treatment goals and maintaining medication adherence.

• Monitoring: Regular checks for signs of adrenal crisis, growth parameters, and electrolyte imbalances.

• Support: Emotional support to families, particularly concerning gender identity issues in affected individuals.

• Emergency preparedness: Educating families on the signs of adrenal crisis and the importance of carrying emergency medications.

🧬 Hemoglobinopathies

Hemoglobinopathies Definition: Genetic conditions that result from mutations in the genes coding for hemoglobin chains (alpha and beta globins).

These mutations can lead to abnormal hemoglobin molecules, causing various clinical manifestations.

🩸 Normal Hemoglobin

Hemoglobin (Hb) is the substance within red blood cells which carries oxygen around the body.

Normal hemoglobin is made up of different globin (polypeptide) chains with heme molecules containing iron. The globin chains combine to make different types of hemoglobin. The structure of each globin chain in hemoglobin is genetically determined.

Normal hemoglobin is called hemoglobin A and consists of:

• 2 alpha (αα) globin chains

• 2 beta (ββ) globin chains

Adult red blood cells normally contain the following hemoglobin chain combinations:

• hemoglobin A (α2β2α2​β2​) >95%

• hemoglobin A2 (α2δ2α2​δ2​) 2% to 3.4%

• fetal hemoglobin F (α2γ2α2​γ2​) <1%

Most common forms of hemoglobinopathies, like sickle cell disease, follow an autosomal recessive pattern, meaning both parents must carry the abnormal gene to produce an affected child.

📉 Symptoms

Symptoms can vary widely depending on the specific type of hemoglobinopathy and its severity, including:

• Anemia: Fatigue, pallor, weakness.

• Sickle cell disease symptoms: Pain crises ("sickle cell crises"), swelling of hands and feet, increased susceptibility to infections, delayed growth in children.

• Thalassemia symptoms: Bone deformities, growth delays, jaundice, and abnormal heart rhythms due to iron overload.

🧪 Diagnosis

Diagnosis typically involves:

• Blood tests: Complete blood count (CBC) to assess hemoglobin levels.

• Hemoglobin electrophoresis: To identify different types of hemoglobin present (e.g., HbS in sickle cell disease, HbA2 and HbF in thalassemia).

• Genetic testing: To confirm specific mutations.

❗ Complications

Complications from hemoglobinopathies can include:

• Sickle cell disease: Acute chest syndrome, stroke, organ damage, and frequent infections.

• Thalassemia: Iron overload requiring chelation therapy, growth retardation, and cardiac or endocrine complications.

• Splenic dysfunction: Increased risk of infections due to spleen damage or dysfunction.

⚙ Pathophysiology

In sickle cell disease, a single nucleotide mutation leads to the production of abnormal hemoglobin (HbS) that polymerizes under low oxygen tension, causing red blood cells to assume a sickle shape. These sickled cells can block blood flow and cause pain crisis due to infarction.

In thalassemia, imbalances in globin chain production led to ineffective erythropoiesis, anemia, and excess iron accumulation from repeated blood transfusions or increased intestinal absorption.

🏥 Medical Management

Medical management strategies include:

• Sickle Cell Disease: Pain management, hydration, hydroxyurea (to increase fetal hemoglobin production), blood transfusions, and bone marrow transplant in severe cases.

• Thalassemia: Regular blood transfusions, iron chelation therapy to manage iron overload, and possibly gene therapy in research stages.

• Vaccination and antibiotics: To prevent infections, especially in patients with functional asplenia.

👩‍⚕ Nursing Management

Nursing management involves:

• Education: Teaching patients and families about the condition, treatment protocols, and potential complications.

• Monitoring: Regular assessments of hemoglobin levels, signs of anemia, and complications.

• Pain management: For patients with sickle cell disease, implementing appropriate pain relief strategies during crises.

• Emotional support: Counseling for patients and families dealing with chronic illness.

🧪 Organic Acid Disorders (OADs)

Organic Acid Disorders (OADs) Definition: Genetic conditions that result in the impaired metabolism of certain organic acids due to enzyme deficiencies.

This leads to the buildup of organic acids, which can be toxic and disrupt normal physiological processes.

There are about more than 65 disorders classified under organic acidemia.

🧬 Causes

OADs are primarily caused by genetic mutations that affect enzymes involved in the metabolic pathways of amino acids, carbohydrates, and fats. Specific causes include:

• Mutations in genes encoding for enzymes such as acyl-CoA dehydrogenases and porphyrin synthases.

• Conditions like propionic acidemia, methylmalonic acidemia, and isovaleric acidemia, which are examples of specific organic acidemias.

📉 Symptoms

Symptoms can vary widely but often include:

• Developmental delays in infants and children

• Lethargy or poor feeding

• Vomiting

• Metabolic acidosis

• Hypoglycemia

• Failure to thrive

• Seizures

⚙ Pathophysiology

The pathophysiology of OADs involves the disruption of normal metabolic pathways, leading to the accumulation of organic acids. These acids can interfere with cellular functions and lead to:

• Altered energy metabolism

• Increased production of toxic metabolites

• Disruption in the balance of electrolytes and pH in the blood

🧪 Diagnosis

Diagnosis typically involves:

• Clinical Evaluation: Assessing symptoms and family history.

• Laboratory Tests: Blood and urine tests to measure organic acid levels.

• Genetic Testing: To identify specific enzyme deficiencies or genetic mutations.

❗ Complications

If untreated, organic acid disorders can lead to severe complications, such as:

• Neurological impairment

• Respiratory failure

• Cardiomyopathy

• Renal failure

• Death in severe cases

🏥 Treatment of Metabolic Acidosis

• Treat the condition that first caused the imbalance

• Remove toxins: dialysis, hemofiltration and exchange transfusion

• Interrupt catabolic state

  • NaHCO3 infusion for HCO3 <22mEq/L

  • Stop protein intake

  • Give carnitine (100-300 mg/kg)

• Restoration of fluids and treatment of underlying cause

• Long term

  • Protein restricted diet (special formulas if available)

  • Carnitine

  • Vitamins (Vit. B12, Vit. B1, Vit. B2, biotin)

Here is a table of organic acidemias and their treatments:

👩‍⚕ Nursing Care

Nursing care for patients with OADs involves:

• Monitoring Vital Signs: Watching for signs of metabolic instability.

• Assessing Nutritional Status: Ensuring appropriate dietary management.

• Educating Families: About the condition, dietary restrictions, and how to manage metabolic emergencies.

• Providing Support: Assisting with emotional and psychological aspects of living with a chronic condition.

🍄 Fatty Acid Oxidation Disorders (FAODs)

Fatty Acid Oxidation Disorders (FAODs) Definition: Genetic disorders caused by deficiencies in enzymes involved in the oxidation of fatty acids in the mitochondria.

This leads to an inability to properly metabolize fats, resulting in the accumulation of fatty acids and toxic metabolites in the body.

📉 Symptoms

Symptoms of FAODs in newborns can vary but often include:

• Nausea and Vomiting

• Lethargy or decreased activity

• Hypoglycemia (low blood sugar)

• Hypoketotic metabolic acidosis

• Failure to thrive

• Muscle weakness or hypotonia

• Seizures

• Jaundice

• Possible sudden coma or sudden death in severe cases

⚙ Pathophysiology

In FAODs, the deficiency of specific enzymes prevents the body from converting fatty acids into acyl-CoA, which is necessary for their entry into the mitochondria for oxidation. This leads to:

• Accumulation of long-chain fatty acids or their metabolites in the bloodstream and tissues.

• A shift from fatty acid metabolism to glucose metabolism, which can lead to hypoglycemia during fasting.

• Disruption of normal energy production, particularly during periods of fasting or stress when the body needs to mobilize stored fats.

🧪 Diagnosis

Diagnosis often involves several steps:

• Newborn Screening: Most FAODs can be detected through routine newborn screening tests that check for specific acylcarnitines in blood samples.

• Clinical Evaluation: Assessment of symptoms, family history, and physical examination.

• Blood Tests: To measure levels of fatty acids, acylcarnitines, and other metabolites.

• Genetic Testing: To identify specific enzyme deficiencies or mutations related to FAODs.

❗ Complications

Complications of FAODs can include:

• Severe hypoglycemia, leading to neurological injury

• Cardiomyopathy

• Liver dysfunction

• Rhabdomyolysis (muscle damage)

• Sudden illness or metabolic crisis during fasting or illness, which can be life-threatening

• Long-term neurological deficits if not properly managed

🏥 Management

Management of FAODs involves:

• Dietary Modifications: Implementing a high-carbohydrate, low-fat diet to avoid prolonged fasting and to provide sufficient energy and nutrients.

• Supplementation: Providing medium-chain triglycerides (MCTs) as they can bypass the defective metabolic pathway.

• Emergency Treatments: Administering intravenous glucose during metabolic crises to rapidly correct hypoglycemia.

• Regular Monitoring: Frequent follow-up with metabolic specialists to monitor metabolic status and adjust dietary plans accordingly.

👩‍⚕ Nursing Care

Nursing care for infants with FAODs includes:

• Monitoring Vital Signs: Regular checks for signs of metabolic instability, hypoglycemia, or distress.

• Assessment of Nutritional Intake: Ensuring adherence to the prescribed dietary regimen, along with monitoring growth and development.

• Education for Parents: Teaching about the disorder, dietary restrictions, and recognizing symptoms of potential metabolic crises.

• Providing Psychological Support: Offering emotional support for families dealing with the chronic nature of the disorder and its implications on lifestyle.

💊 Biotinidase Deficiency

Biotinidase Deficiency Definition: A genetic disorder that occurs due to mutations in the BTD gene, which encodes the enzyme biotinidase responsible for cleaving biotin from dietary sources and recycling it for use by the body.

Without sufficient biotin, metabolic processes become disrupted.

📉 Symptoms

Symptoms of biotinidase deficiency can be variable and may include:

• Skin rashes (e.g., seborrheic dermatitis)

• Hair loss (alopecia)

• Hypotonia (decreased muscle tone)

• Developmental delays

• Seizures

• Lethargy or poor feeding

• Recurrent infections

• Neurological disturbances, such as ataxia or sensory abnormalities

Symptoms may present in infancy or early childhood, but some individuals may be asymptomatic until later in life without timely treatment.

⚙ Pathophysiology

The pathophysiology of biotinidase deficiency involves:

• Deficiency of biotin, leading to impaired function of biotin-dependent carboxylase enzymes, which are crucial for various metabolic pathways.

• Disruption of gluconeogenesis, fatty acid synthesis, and amino acid metabolism, resulting in metabolic disturbances.

• Accumulation of potentially toxic metabolites due to dysfunctional enzymatic pathways.

🧪 Diagnosis

Diagnosis typically involves:

• Newborn Screening:

Biotinidase Deficiency 🧬

Biotinidase deficiency is often detected through routine newborn screening programs that measure biotinidase enzyme activity in blood samples.

Diagnosis

• Clinical Evaluation: Assessing symptoms and reviewing family medical history for genetic factors.

• Genetic Testing: To confirm mutations in the BTD gene.

Complications

Without treatment, biotinidase deficiency can lead to:

• Neurological damage, including cognitive impairment and developmental delays

• Severe dermatological issues

• Increased susceptibility to infections

• Potentially life-threatening metabolic crises

Treatment

The primary management for biotinidase deficiency is lifelong oral administration of biotin supplements, typically starting at a dose of 5-20mg per day, to replace the biotin the body cannot recycle due to the enzyme deficiency. Early diagnosis and treatment are crucial to prevent irreversible neurological damage and developmental delays.

Nursing Care

Nursing care for infants with biotinidase deficiency involves:

• Monitoring: Regularly checking vital signs and observing for symptoms such as skin rashes or developmental delays.

• Educating Families: Teaching about the condition, treatment adherence, and recognizing potential symptoms that require medical attention.

• Facilitating Referrals: Connecting families to support services and specialists, such as genetic counselors or dietitians, for comprehensive care.

• Emotional Support: Offering support to families navigating the implications of a chronic condition.

Cystic Fibrosis (CF) 🫁

Cystic fibrosis is a hereditary condition characterized by dysfunctional ion transport in epithelial cells, leading to the accumulation of thick mucus in various organs.

Genetics of CF

To have CF, you must inherit two copies of the CFTR gene that contain mutations, one copy from each parent. That means that each parent must either have CF or be a carrier of a CFTR gene mutation.

Signs and Symptoms in Newborns

• Meconium ileus: A blockage in the intestine due to thick meconium.

• Failure to thrive: Poor growth and weight gain despite adequate caloric intake.

• Salty skin: Parents may notice that the baby's skin tastes salty when kissed.

• Respiratory symptoms: Wheezing, coughing, or frequent respiratory infections.

• Digestive issues: Difficulty absorbing nutrients, which can lead to diarrhea and oily stools.

Pathophysiology

The CFTR protein regulates the transport of chloride and bicarbonate ions across epithelial cell membranes.

In CF, mutations in the CFTR gene disrupt chloride transport, causing an imbalance of salt and water on epithelial surfaces. This results in thick mucus production, leading to blockages and inflammation in various organs, especially the lungs and pancreas. CFTR stands for Cystic Fibrosis Transmembrane Conductance Regulator

Diagnosis

Cystic fibrosis is typically diagnosed through:

• Newborn screening: A blood test measuring immunoreactive trypsinogen (IRT) levels; elevated levels may indicate CF.

• Sweat test: Measures the concentration of chloride in sweat; a higher than normal level suggests CF.

• Genetic testing: Identifies mutations in the CFTR gene.

Sweat Test Results

(Note: Some sources list slightly different ranges, such as 0-39 unlikely and 40-59 intermediate)

Complications

Complications of cystic fibrosis can include:

• Chronic lung infections

• Respiratory failure

• Pancreatic insufficiency

• Cirrhosis of the liver

• Diabetes (CF-related)

Medical Management

Medical management of cystic fibrosis focuses on managing symptoms and preventing complications:

• Airway clearance techniques: Chest physiotherapy and devices to help clear mucus.

• Medications:

  • Mucolytics (e.g., dornase alfa) to thin mucus.

  • Inhaled antibiotics to treat lung infections.

  • Bronchodilators to improve airflow.

  • Pancreatic enzyme replacement therapy to aid digestion.

• Nutritional support: High-calorie diets and vitamin supplementation.

Nursing Management

Nursing management for newborns with cystic fibrosis involves:

• Monitoring growth and nutritional status: Regularly assess weight and growth patterns.

• Administering medications: Ensuring adherence to treatment regimens.

• Educating parents: Instructing on airway clearance techniques and nutrition.

• Providing emotional support: Helping families cope with the diagnosis and ongoing management.

• Coordinating care: Working with a multidisciplinary team for comprehensive care.

Severe Combined Immunodeficiency (SCID) 🛡

SCID is defined as a group of inherited disorders that result in the absence or dysfunction of T lymphocytes and B lymphocytes. It is often referred to as "bubble boy disease" due to the necessity for affected individuals to live in sterile environments to avoid infections.

Signs and Symptoms

In newborns, signs and symptoms of SCID may include:

• Frequent and severe infections (viral, bacterial, and fungal)

• Failure to thrive

• Chronic diarrhea

• Oral thrush

• Rash (e.g., eczema)

• Family history of SCID or other immune deficiencies

Complications

Without early diagnosis and treatment, complications from SCID can include:

• Life-threatening infections

• Autoimmunity

• Severe malnutrition

• Death

Pathophysiology

SCID results from various genetic mutations leading to a failure in the development or function of T and B lymphocytes:

• X-linked SCID: Mutations in the IL2RG gene affecting the common gamma chain involved in multiple interleukin receptors.

• Adenosine deaminase deficiency (ADA-SCID): Mutations in the ADA gene, leading to the accumulation of toxic metabolites that impair lymphocyte development.

• Other genetic causes: Various autosomal recessive mutations affecting different signaling pathways and components of lymphocyte development.

Diagnosis

Diagnosis of SCID typically involves:

• Newborn screening: For severe lymphopenia or T-cell receptor excision circles (TRECs) via a blood test.

• Complete blood count (CBC): To evaluate white blood cell counts and lymphocyte subtypes.

• Immunological testing: Assessing antibody levels and the presence of functional T and B cells.

• Genetic testing: Confirming specific mutations in known SCID-associated genes.

Treatment

Treatment for SCID includes:

• Hematopoietic stem cell transplantation (HSCT): The most definitive treatment option.

• Gene therapy: In certain types of SCID, particularly ADA-SCID.

• Immunoglobulin replacement therapy: To provide passive immunity while awaiting definitive treatment.

• Antibiotics and antifungal medication: To prevent and treat infections.

Nursing Management

Nursing management involves:

• Monitoring: Regular assessment of vital signs, signs of infection, and growth/weight parameters.

• Education: Informing families about SCID, treatment options, and infection prevention strategies.

• Supportive care: Including nutritional support and managing symptoms related to infections or side effects of treatment.

• Infection control: Implementing strict hygiene measures and providing guidance on avoiding potential infection sources.

Critical Congenital Heart Disease (CCHD) 🫀

CCHD includes congenital heart defects that are severe enough to result in significant clinical symptoms and require immediate medical attention.

Examples include:

• Hypoplastic left heart syndrome

• Transposition of the great arteries

• Tetralogy of Fallot

• Total anomalous pulmonary venous return

• Critical aortic stenosis

Critical congenital heart diseases (defects) can be broadly classified into four categories, including those with inadequate pulmonary blood flow, inadequate systemic blood flow, inadequate intracardiac shunting, and ventricular dysfunction.

Signs and Symptoms

Signs and symptoms of CCHD in newborns can include:

• Cyanosis

• Difficulty breathing

• Poor feeding

• Fast heart rate

• Cold extremities

• Murmurs

Pathophysiology

The pathophysiological mechanisms vary depending on the specific type of CCHD, but they generally involve structural defects in the heart that disrupt normal blood flow. Key concepts include:

• Decreased systemic blood flow: Due to obstruction or insufficient left heart structures (e.g., hypoplastic left heart syndrome).

• Mixed oxygenated and deoxygenated blood: In conditions like transposition of the great arteries, where the aorta and pulmonary artery are switched, leading to parallel rather than series circulation.

• Increased pulmonary blood flow: As seen in conditions like total anomalous pulmonary venous return, causing high blood flow to the lungs and potential congestive symptoms.

Complications

Complications of CCHD can include:

• Heart failure

• Hypoxemia

• Arrhythmias

• Growth retardation

• Death

Diagnosis

Diagnosis typically involves:

• Physical examination

• Pulse oximetry screening

• Echocardiogram

• Chest X-ray

Management

Management strategies include:

• Medications: Prostaglandin E1, Diuretics and afterload reducers

• Surgical interventions: Early surgical repair or palliation of critical defects (e.g., anastomosis, shunt creation).

• Cardiac catheterization: For diagnosis and intervention in some cases.

Nursing Care

Nursing care for newborns with CCHD involves:

• Monitoring: Continuous monitoring of vital signs, oxygen saturation, and signs of heart failure or respiratory distress.

• Feeding support: Providing guidelines for feeding techniques to enhance caloric intake while minimizing energy expenditure.

• Education: Informing parents about the condition, treatment options, and signs of complications to watch for.

• Emotional support: Offering support to families dealing with the stress of diagnosis and ongoing management.

• Coordination of care: Collaborating with cardiologists, surgeons, and other specialists to provide comprehensive management.

Growth Failure (Failure to Thrive - FTT) 📉

Failure to thrive refers to inadequate growth or weight gain in infants and children. Specifically, in newborns, it can be defined as a condition where the infant's weight falls below the 5th percentile for age or there is a significant downward trend in weight, indicating insufficient caloric intake or nutrient absorption.

Pathophysiology

FTT can arise from a variety of factors that affect an infant's ability to gain weight and grow adequately. These include:

• Inadequate caloric intake

• Increased caloric requirements

• Malabsorption disorders

• Psychosocial factors

Symptoms

• Lack of weight gain or weight loss

• Decreased appetite or poor feeding patterns

• Weakness or lethargy

• Delayed developmental milestones

• Irritability or fussiness

• Poor muscle tone

Diagnosis

Diagnosing failure to thrive involves:

1. Growth Monitoring: Regularly measuring weight, length, and head circumference to compare with growth charts.

2. Medical History: Gathering information on feeding habits, family history, and any medical concerns.

3. Physical Examination: Assessing for any signs of underlying medical conditions (e.g., dehydration, signs of infection).

4. Laboratory Tests: Conducting blood tests, urine tests, or imaging studies as needed to identify underlying causes (e.g., metabolic disorders, infections).

Medical Management

The management of FTT focuses on treating underlying causes and improving nutritional intake. Interventions may include:

• Nutritional Support: Adjusting feeding strategies (increasing formula volume, introducing high-calorie supplements).

• Treating Underlying Conditions: Addressing any medical issues identified during diagnosis.

• Monitoring Growth: Regular follow-ups to ensure the infant is gaining weight appropriately.

Nursing Management

Nursing interventions may include:

• Education for Parents: Teaching proper feeding techniques, recognizing hunger cues, and understanding the importance of regular feeding.

• Emotional Support: Providing support and encouragement to caregivers and addressing any psychological concerns they may have.

• Care Coordination: Collaborating with dietitians, pediatricians, and social services if needed.

• Ongoing Assessment: Continuously monitoring the infants weight and growth progress, and adjusting care plans as necessary.

Colic (Paroxysmal Abdominal Pain) 😫

Colic is commonly defined as excessive crying in an otherwise healthy infant. It typically manifests as episodes of crying lasting for more than three hours a day, occurring at least three days a week, for three weeks or longer, often starting around two weeks of age and improving by three to four months.

Causes

The exact cause of colic is not fully understood, but several factors may contribute, including:

• Gastrointestinal Factors: Issues such as gas, constipation, or intolerance to certain foods (e.g., cow's milk protein intolerance).

• Neurological Maturity: Immature nervous system development that may lead to overstimulation and inability to self-soothe.

• Environmental Stressors: Parenting stress, exposure to loud noises, or chaotic environments can affect an infant's temperament.

• Dietary Factors: Maternal diet (in breastfeeding mothers) or formula intolerance can affect the infant's well-being.

Pathophysiology

Colic may involve several physiological processes:

• Gastrointestinal Sensitivity: Increased gas production and intestinal motility can cause discomfort and pain.

• Central Nervous System Development: The infant's increasing ability to perceive environmental stressors may lead to overstimulation and crying.

• Neurotransmitter Imbalance: Changes in serotonin levels and other neurotransmitters may influence mood and pain perception in infants.

Symptoms

Symptoms of colic can include:

• Intense and inconsolable crying, usually occurring in the late afternoon or evening

• Clenching of fists, arching the back, and pulling legs toward the belly during crying episodes

• Signs of discomfort, such as facial grimacing

• Occasional gas and bowel movement irregularities

Complications

While colic is not harmful in itself, it can lead to potential complications:

• Increased parental stress and frustration

• Potential for altered parent-child bonding

• The risk of neglect

Diagnosis

Diagnosing colic typically involves:

1. Clinical Assessment: A thorough history and observation of the infant's behavior, including crying patterns and family dynamics.

2. Exclusion of Other Conditions: Ruling out other potential causes of excessive crying through physical examinations and possibly laboratory tests (e.g., to check for infections or metabolic disturbances).

Medical Management

Medical management may include:

• Dietary Adjustments: Maternal dietary modifications or hypoallergenic formulas.

• Medications: Simethicone for gas relief (limited evidence of efficacy).

• Probiotics: Some studies suggest certain probiotics may be beneficial.

Nursing Management

• Education: Teaching parents about normal infant behavior and reassurance that colic is generally a self-limiting condition.

• Coping Strategies: Providing strategies for soothing the infant.

• Support Resources: Connecting families with support groups or counseling services if needed for stress management.

• Regular Follow-Up: Monitoring the infant's growth and development and tracking the frequency and duration of crying episodes to assess improvement.

Sudden Infant Death Syndrome (SIDS) 😔

Sudden Infant Death Syndrome (SIDS) refers to the sudden and unexplained death of an apparently healthy infant, usually during sleep, typically occurring in infants aged one month to one year. It is sometimes referred to as "crib death" because it often happens when the baby is in bed or in a crib.

Causes

The exact cause of SIDS remains unknown, but several factors have been identified that may increase the risk:

• Sleep Position: Babies placed on their stomachs or sides to sleep are at higher risk.

• Sleep Environment: Soft bedding, pillows, and toys in the crib, as well as overheating due to excessive clothing or room temperature.

• Maternal Factors: Maternal smoking, alcohol use during pregnancy, and inadequate prenatal care.

• Infant Factors: Prematurity, low birth weight, or being part of a multiple birth (twins, triplets, etc.).

• Age and Gender: SIDS is more common in male infants and typically occurs between two and four months of age.

Pathophysiology

While the precise mechanisms behind SIDS are not fully understood, potential contributing factors include:

• Sleep-Awake Regulation: Infants may have an immature central nervous system that affects their arousal response to asphyxia or hypoxia during sleep.

• Deficits in Autonomic Control: Infants may experience abnormalities in autonomic regulation, affecting heart rate and breathing patterns during sleep.

• Genetic Predisposition: There may be genetic factors that influence susceptibility to SIDS.

Risk Factors

• Smoking exposure during/after pregnancy

• Lack of prenatal care

• Unsafe sleep positions/environment

• Premature birth or low birth weight

• Overheating during sleep

• Alcohol exposure in pregnancy

• Male infants (higher risk)

• Sibling of a SIDS victim

• Twin birth

• History of apnea or stopped breathing

Symptoms

SIDS is characterized by the absence of specific symptoms before death, as it occurs unexpectedly. Parents may observe:

• The infant appearing healthy before sleep

• Unusual positions during sleep

• No evidence of struggle or distress

Diagnosis

SIDS is a diagnosis of exclusion, meaning it is identified after ruling out other causes of sudden infant death. The diagnostic process includes:

• Autopsy: A thorough autopsy to search for underlying medical conditions or abnormalities.

• Medical History: Gathering information from parents regarding health, sleeping habits, and behavioral patterns.

• Scene Investigation: Examining the sleep environment and circumstances surrounding the infant's death.

Complications

SIDS itself does not cause complications, but its occurrence can result in significant emotional trauma for families and may lead to:

• Grief and mental health issues

• Strain on family relationships

Medical Management

Currently, there is no specific medical treatment for SIDS, but the focus is on prevention and risk reduction:

• Education: Educating parents about safe sleep practices is crucial.

• Post-Mortem Analysis: If SIDS is suspected, medical professionals may conduct investigations to confirm the diagnosis or rule out other causes.

Nursing Management

Nursing interventions are essential in promoting awareness and prevention of SIDS:

• Parental Education: Teach parents the importance of placing infants on their backs to sleep, using a firm mattress, avoiding soft bedding, and maintaining a smoke-free environment.

• Encouragement of Breastfeeding: Strong evidence supports that breastfeeding may reduce the risk of SIDS.

• Regular Follow-Up: Monitoring the health and development of infants and providing continued education for parents on safe sleep recommendations.

• Support Systems: Provide emotional support and resources for families affected by SIDS, including counseling and support groups for grieving parents.